Alton Gregg H has filed 22 insider transactions across 3 companies since December 2022.
Most recent transaction: a grant/award of 28326 shares of NOVAVAX INC ($NVAX) on June 20, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 20, 2025 | NOVAVAX INC | $NVAX | Alton Gregg H | Director | A | Stock Option (Right to Buy) | 28326 | $6.42 | 28,326.0000 | 152,190,000 | 9999.99% | 0.02% |
| June 20, 2025 | NOVAVAX INC | $NVAX | Alton Gregg H | Director | A | Restricted Stock Units | 18884 | $0.00 | 18,884.0000 | 152,190,000 | 9999.99% | 0.01% |
| June 12, 2025 | NOVAVAX INC | $NVAX | Alton Gregg H | Not found | M | Restricted Stock Units | 10420 | $0.00 | 0.0000 | 152,190,000 | 100.00% | 0.01% |
| June 12, 2025 | NOVAVAX INC | $NVAX | Alton Gregg H | Not found | M | Common Stock | 10420 | $0.00 | 28,805.0000 | 152,190,000 | 56.68% | 0.01% |
| June 10, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Alton Gregg H | Not found | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 113,480,000 | 9999.99% | 0.01% |
| Dec. 31, 2024 | NOVAVAX INC | $NVAX | Alton Gregg H | Director | A | Common Stock | 1982 | $8.61 | 18,385.0000 | 160,049,000 | 12.08% | 0.00% |
| March 31, 2024 | NOVAVAX INC | $NVAX | Alton Gregg H | Director | A | Common Stock | 3420 | $4.90 | 7,220.0000 | 100,768,000 | 90.00% | 0.00% |
| June 30, 2024 | NOVAVAX INC | $NVAX | Alton Gregg H | Director | A | Common Stock | 1202 | $13.93 | 15,092.0000 | 100,768,000 | 8.65% | 0.00% |
| Sept. 30, 2024 | NOVAVAX INC | $NVAX | Alton Gregg H | Director | A | Common Stock | 1311 | $12.77 | 16,403.0000 | 100,768,000 | 8.69% | 0.00% |
| June 25, 2024 | Lunai Bioworks Inc. | $LNAI | Alton Gregg H | Director | A | Option to purchase shares of common stock | 48137 | $0.00 | 48,137.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | NOVAVAX INC | $NVAX | Alton Gregg H | Not found | M | Restricted Stock Units | 6670 | $0.00 | 0.0000 | 100,768,000 | 100.00% | 0.01% |
| June 12, 2024 | NOVAVAX INC | $NVAX | Alton Gregg H | Not found | M | Common Stock | 6670 | $0.00 | 10,470.0000 | 100,768,000 | 175.53% | 0.01% |
| June 12, 2024 | NOVAVAX INC | $NVAX | Alton Gregg H | Not found | A | Stock Option (Right to Buy) | 15630 | $15.86 | 15,630.0000 | 100,768,000 | 9999.99% | 0.02% |
| June 12, 2024 | NOVAVAX INC | $NVAX | Alton Gregg H | Not found | A | Restricted Stock Units | 10420 | $0.00 | 10,420.0000 | 100,768,000 | 9999.99% | 0.01% |
| May 17, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Alton Gregg H | Not found | A | Stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 111,742,000 | 9999.99% | 0.03% |
| Dec. 27, 2023 | Lunai Bioworks Inc. | $LNAI | Alton Gregg H | Director | A | Option to purchase shares of common stock | 23810 | $0.00 | 23,810.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2023 | NOVAVAX INC | $NVAX | Alton Gregg H | Director | M | Restricted Stock Units | 3100 | $0.00 | 0.0000 | 78,183,000 | 100.00% | 0.00% |
| June 10, 2023 | NOVAVAX INC | $NVAX | Alton Gregg H | Director | M | Common Stock | 3100 | $0.00 | 3,800.0000 | 78,183,000 | 442.86% | 0.00% |
| June 12, 2023 | NOVAVAX INC | $NVAX | Alton Gregg H | Director | A | Stock Option (Right to Buy) | 7710 | $0.00 | 7,710.0000 | 78,183,000 | 9999.99% | 0.01% |
| June 12, 2023 | NOVAVAX INC | $NVAX | Alton Gregg H | Director | A | Restricted Stock Units | 6670 | $0.00 | 6,670.0000 | 78,183,000 | 9999.99% | 0.01% |
| May 19, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Alton Gregg H | Director | A | Stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 115,966,000 | 9999.99% | 0.03% |
| Dec. 27, 2022 | Lunai Bioworks Inc. | $LNAI | Alton Gregg H | Director | A | Option to purchase shares of common stock | 57252 | $0.00 | 57,252.0000 | 0 | 9999.99% | 0.00% |